792
Participants
Start Date
January 20, 2022
Primary Completion Date
March 21, 2023
Study Completion Date
March 21, 2023
Cytisinicline
film-coated oral tablets containing 3 mg cytisinicline
Placebo
film-coated oral tablets containing matched placebo
Behavioral support
Behavioral support sessions by a qualified study site staff member will be participant-driven and will include direct engagement with the subject about their attempt to quit smoking. Each session will last approximately 10 minutes.
Health Research of Hampton Toads, Inc, Newport News
Trial Management Associates, LLC, Wilmington
Jacksonville Center for Clinical Research, Jacksonville
Accel Research Sites - DeLand Clinical Research Unit, DeLand
Alliance for Multispecialty Research, LLC, Fort Myers
Clinical Research Associates, Inc., Nashville
Aventiv Research Inc, Columbus
Velocity Clinical Research, Inc., Cleveland
MediSphere Medical Research Center, LLC, Evansville
Affinity Health Corp, Oak Brook
Intend Research, Norman
Global Medical Institutes LLC; Princeton Medical Institute, Princeton
Lead Sponsor
Achieve Life Sciences
INDUSTRY